S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Hospira Launches Q Core Sapphire Infusion System in the United States (2013/10/23)|
|Hospira Unveils New Quality Laboratory and Investments at Rocky Mount, N.C., Plant ()|
|Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to be approved in Europe ()|
|Hospira Reports Second-Quarter 2013 Results ()|
|Hospira Reports Third-Quarter 2013 Results ()|
|Hospira Reports Fourth-Quarter and Full-Year 2013 Results (2014/2/12)|
|Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to be approved in Europe (2013/9/10)|
|Hospira Shares Results From Two Open-label Extension Studies for Biosimilar Infliximab in Patients With Rheumatoid Arthritis or Ankylosing Spondylitis (2013/10/31)|
|Hospira to Present at the Morgan Stanley Global Healthcare Conference (2013/8/13)|
|Hospira to Present at the J.P. Morgan 32nd Annual Healthcare Conference Jan. 15, 2014 ()|
Click above to view more mutual fund data and stats for hsp - Hospira, Inc..